Mineralys Therapeutics MLYS
NASDAQ MLYS
$15.52 -0.29 (-1.83%)
At close: Nov 10, 2026 · 4:00 PM EST

Mineralys Therapeutics (MLYS) Non Operating Income (2022 - 2026)

Updated

Mineralys Therapeutics (MLYS) posted Non Operating Income of $2.76 million for Q3 2026, down 34.3% from $4.2 million a year earlier and down 44.5% from the prior quarter.

Analysis

Mineralys Therapeutics (MLYS) Non Operating Income (2022 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Non Operating Income at Mineralys Therapeutics was $19.78 million, up 55.4% year-over-year; for FY2025, it was $15.95 million, up 9.3% from FY2024.

  • Annual Non Operating Income has increased for three consecutive years, with a three-year compound annual growth rate of 111.8% (FY2022 to FY2025).
  • In prior years, Mineralys Therapeutics' Non Operating Income was $14.59 million in FY2024 (+14.4%), $12.76 million in FY2023 (+659.5%) and $1.68 million in FY2022.
  • The Q3 2026 figure stands as the lowest quarterly Non Operating Income since Q1 2025.
  • On a year-over-year basis, Non Operating Income increased in four of the last eight quarters, with growth averaging 28.7%.
  • The strongest year-over-year quarter for Non Operating Income in the past five years was Q3 2023, with growth of 371.5%; the weakest was Q1 2025, with a decline of 42.0%.
  • According to Business Quant data, Non Operating Income for the three prior quarters was $4.97 million (Q2 2026), $6 million (Q1 2026) and $6.05 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Mineralys Therapeutics 1.37 Bn -1.21 Bn - 2.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.76 Mn
Jun 30, 2026 4.97 Mn
Mar 31, 2026 6.00 Mn
Dec 31, 2025 6.05 Mn
Sep 30, 2025 4.20 Mn
Jun 30, 2025 3.47 Mn
Mar 31, 2025 2.24 Mn
Dec 31, 2024 2.82 Mn
Sep 30, 2024 3.76 Mn
Jun 30, 2024 4.15 Mn
Mar 31, 2024 3.85 Mn
Dec 31, 2023 3.32 Mn
Sep 30, 2023 3.51 Mn
Jun 30, 2023 3.59 Mn
Mar 31, 2023 2.33 Mn
Dec 31, 2022 935,000.00
Sep 30, 2022 745,000.00
API Access

Mineralys Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=MLYS&period=max&api_key=YOUR_API_KEY